Leonard Zehr, Author at BioTuesdays

Feature

TRACON Pharma gears for important near-term milestones

TRACON Pharmaceuticals (NASDAQ:TCON) is expected to report several important potential milestones over the next two quarters, including two randomized data points from its product development pipeline.

November 20, 2018

Feature

Robert Foster swinging for the fence again with ContraVir Pharma

Dr. Robert Foster is teeing up another possible home run as the new CEO of ContraVir Pharmaceuticals (NASDAQ:CTRV) and its lead programs for liver disease arising from chronic viral infection and NASH (non-alcoholic...

November 13, 2018

Feature

Trendlines cites hands-on approach to growth of its investment portfolio

With 11 years of progressive growth in the value of its expanding portfolio, The Trendlines Group (SGX:42T; OTCQX:TRNLY), an Israeli investment company, takes a very hands-on approach with its early-stage medical and...

November 6, 2018

Feature

In conversation with Dr. Femida Gwadry-Sridhar of Pulse Infoframe

As founder and CEO of closely-held Pulse Infoframe, a leading cloud-based healthcare data insights company, Dr. Femida Gwadry-Sridhar’s resume boasts a deep background as a pharmacist, epidemiologist and methodologist...

October 30, 2018

Feature

MagnetTx developing combined MRI and linac for cancer radiation therapy

By Len Zehr Closely-held MagnetTx Oncology Solutions filed a 510(k) application with the FDA in September for its Aurora RT device, which combines the accuracy of magnetic resonance imaging (MRI) with linear accelerator...

October 23, 2018

Feature

Rgenix’s discovery platform identifying novel RNA-regulated cancer targets

By Len Zehr Closely-held Rgenix has identified novel cancer targets regulated by microRNA pathways, which are key drivers of cancer progression, and developed first-in-class treatments that have the potential to...

October 16, 2018

Feature

Lobo Genetics enabling safe cannabis use with DNA testing

Closely-held Lobo Genetics is readying the initial launch in the current quarter of 2018 of its Lobo Cube DNA testing device to bring the science of cannabis genetics to doctors and consumers.

October 9, 2018

Feature

CHF Solutions expanding commercialization of Aquadex FlexFlow for fluid overload

By Len Zehr CHF Solutions (NASDAQ:CHFS) has expanded its U.S. commercial team to 13 sales territories for its Aquadex FlexFlow system, an ultrafiltration treatment for patients with fluid overload who have failed...

October 2, 2018

Feature

electroCore focused on U.S. launch of gammaCore for acute treatment of episodic cluster headaches and migraines

By Len Zehr With FDA approval in hand for its gammaCore Sapphire therapy for the acute treatment of episodic cluster headaches and migraines, electroCore (NASDAQ:ECOR) is now focused on commercialization and...

September 25, 2018

Feature

elminda BNA technology unlocking secrets of brain disorders

By Len Zehr Closely-held elminda’s Brain Networks Analytics (BNA) technology is going beyond genetics, imaging and behavioral tests to unlock brain functioning and how the brain changes over time, combining Big Data and...

September 18, 2018

Author - Leonard Zehr

TRACON Pharma gears for important near-term milestones

Robert Foster swinging for the fence again with ContraVir Pharma

Trendlines cites hands-on approach to growth of its investment portfolio

In conversation with Dr. Femida Gwadry-Sridhar of Pulse Infoframe

MagnetTx developing combined MRI and linac for cancer radiation therapy

Rgenix’s discovery platform identifying novel RNA-regulated cancer targets

Lobo Genetics enabling safe cannabis use with DNA testing

CHF Solutions expanding commercialization of Aquadex FlexFlow for fluid overload

electroCore focused on U.S. launch of gammaCore for acute treatment of episodic cluster headaches and migraines

elminda BNA technology unlocking secrets of brain disorders

General

More